Titre :

Proteomic signature for early diagnosis of left ventricular remodeling after myocardial infarction

Auteur(s) :

Heyse, Wilfried [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
MOdel for Data Analysis and Learning [MODAL]
Vandewalle, Vincent [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
MOdel for Data Analysis and Learning [MODAL]
Amouyel, Philippe [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Briend, Guillemette [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
MOdel for Data Analysis and Learning [MODAL]
Bauters, Christophe [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Pinet, Florence [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]

Titre de la manifestation scientifique :

Printemps de la cardiologie 2020

Ville :

Grenoble

Pays :

France

Date de début de la manifestation scientifique :

2020-10-29

Discipline(s) HAL :

Statistiques [stat]/Applications [stat.AP]
Sciences du Vivant [q-bio]/Médecine humaine et pathologie/Cardiologie et système cardiovasculaire
Sciences du Vivant [q-bio]/Biochimie, Biologie Moléculaire/Génomique, Transcriptomique et Protéomique [q-bio.GN]

Résumé en anglais : [en]

Heart failure (HF) remains a main cause of mortality worldwide. The most common cause of HF is coronary artery disease and particularly myocardial infarction (MI). Left ventricular remodelling (LVR) is a progressive ...
Lire la suite >Heart failure (HF) remains a main cause of mortality worldwide. The most common cause of HF is coronary artery disease and particularly myocardial infarction (MI). Left ventricular remodelling (LVR) is a progressive dilatation of the left ventricle that occurs in response to MI and is difficult to predict in clinical practice based on infarct size, infarct location or LV ejection fraction. Several studies have identified LVR as a powerful indicator of a high risk of HF or death after MI. The aim is to identify plasmatic proteins that could predict the occurrence and severity of LVR in order to prevent HF. The REVE and REVE-2 studies have included respectively, 215 and 246 patients with a first anterior MI. The patients have been followed-up with serial echocardiography during one year to quantify LVR. Plasma samples have been collected during hospitalization for both studies, and at 1, 3 and 12 months after MI for REVE-2, allowing to measure 5284 proteins thanks to a high throughput proteomic approach (SOMASCAN). Due to the high dimension of data (more variables than individuals), we used statistical methods performing variable selection to build a proteomic signature of LVR. We showed that REVE and REVE-2 studies share common statistical characteristics (distributions, correlations) allowing us to perform analysis on REVE-2 and use REVE for validation. We confirmed the difficulty to predict LVR using only clinical data, with prediction models explaining at the best 11% of LVR (R²=0,106). Using the proteomic data we explained 30% of LVR (R²=0,297) using a 22-proteins based score built with nested models. We confirmed that LVR is complex to predict even with a huge number of potential biomarkers to explore. Still, we enhanced the predictability of LVR and we intend to find a protein profile of LVR during the year after MI by studying data collected during this period.Lire moins >

Langue :

Anglais

Comité de lecture :

Oui

Audience :

Internationale

Vulgarisation :

Non

Collections :

• Laboratoire Paul Painlevé - UMR 8524

Source :

Harvested from HAL